Analysts expect over 2020 rising revenue Amgen

Tomorrow the American Amgen will publish its past quarters figures. Over the current book year the total revenue will be 25,3 billion USD (consensus estimates). This is slightly more than 2018's revenue of 23,36 billion USD.

Historical revenues and results Amgen plus estimates 2020

stock price

The analysts expect for 2020 a net profit of 9,05 billion USD. For this year most of the analysts expect a profit per share of 15,42 USD. Based on this the price/earnings-ratio is 15,41.

Per share the analysts expect a dividend of 6,31 USD per share. The dividend yield is then 2,65 percent. The average dividend yield of the biotech companies equals a limited 1,16 percent.

Newest target prices around 256 USD

The most recent recommendations for the biotech company are from Oppenheimer & Co, Independent Research and Citigroup.

Based on the current number of shares Amgen's market capitalization equals 149,64 billion USD. The Amgen stock was the past 12 months quite unstable. Since last April the stock is even 37 percent higher. This year the stock price moved between 166 and 245 dollar. Since 2008 the stock price is almost 306 percent higher.

Historical stock prices Amgen past 10 years

stock price amgen

Click here for dividend . On Friday the stock closed at 237,67 USD.

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.